Development and validation of a multivariable prediction rule for detecting a severe acquired ADAMTS13 activity deficiency in patients with thrombotic microangiopathies.

Jorge Martinez Nieto Félix de la Fuente-GonzaloFernando A GonzálezAna VillegasRafael MartínezManuel E FuentesPaloma Ropero

Published in: Clinical chemistry and laboratory medicine (2019)

This could lead to the earlier confirmation or rapid exclusion of TTP when ADAMTS13 testing is not avalilable, facilitating a more suitable therapy based on the aetiology of the TMA.

Keyphrases

early onset
replacement therapy
stem cells
drug induced
bone marrow
cell therapy
smoking cessation